Search filters

List of works by Matthias Pinter

A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade

scientific article published on 09 September 2020

Amelioration of systemic inflammation in advanced chronic liver disease upon beta-blocker therapy translates into improved clinical outcomes

scientific article published on 16 November 2020

Clinical and Genetic Tumor Characteristics of Responding and Non-Responding Patients to PD-1 Inhibition in Hepatocellular Carcinoma

scientific article published on 18 December 2020

Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups

scientific article published on 03 August 2020

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension

scientific article published on 03 December 2019

Letter: programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort-more questions than answers. Authors' reply

scientific article published on 01 July 2019

Letter: programmed cell death protein-1-targeted immunotherapy for advanced hepatocellular carcinoma-authors' reply

scientific article published on 01 August 2019

Letter: sequential or combined systemic treatment for unresectable hepatocellular carcinoma-authors' reply

scientific article published on 01 September 2020

Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?

scholarly article by Matthias Pinter & Wolfgang Sieghart published 2018 in Memo – Magazine of European Medical Oncology

Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different etiologies of advanced chronic liver disease

scientific article published on 02 May 2020

Non-invasive risk stratification after HCV-eradication in patients with advanced chronic liver disease

scientific article published on 13 July 2020

Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2.

scientific article published in March 2018

Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort

scientific article published on 12 April 2019

Review article: systemic treatment of hepatocellular carcinoma

scientific article published on 23 July 2018

Sequential systemic treatment in patients with hepatocellular carcinoma

scientific article published on 20 May 2020

Synthesis and Cytotoxic Activity of Chiral Sulfonamides Based on the 2-Azabicycloalkane Skeleton

scientific article published on 18 May 2020

Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy.

scientific article published in October 2017

The impact of thyroid hormones on patients with hepatocellular carcinoma.

scientific article published on 3 August 2017

Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma

scientific article published on 07 February 2019

Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib

scientific article published on 13 October 2020